CClinicalTrials.gg
Sign In
Status unknownNCT05257239Updated Feb 25, 2022

Acceptability and User Perceptions of Artificial Intelligence-based Mobile Applications Adoption for Weight Management: A Sequential Explanatory Study

An observational study in Weight Management, sponsored by National University Health System, Singapore. Status unknown at 1 site in Singapore. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2022-02-25.

Sponsored by National University Health System, Singapore · Observational

The sponsor has not verified this record recently (last verified Feb 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
600
Ages
21 Years and older
Sex
All
01

Study summary

To understand the user perceptions of AI and non-AI-based mobile apps for weight management in people with overweight and obesity.

02

Conditions studied

  • Weight Management

Browse trials for

03

In context

Body Weight

1,223 studies on the registry are indexed under Body Weight; 131 are open to participants now.

This study's planned enrollment of 600 is above the median of 140 across 238 observational studies indexed under Body Weight.

Browse Body Weight studies →

Lead sponsor

National University Health System, Singapore is the lead sponsor of 40 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Singaporean population

Inclusion criteria

  • Participants will be recruited if they are above 21 years old, have a BMI ≥23kg/m2 and understand English language.

Exclusion criteria

Exclusion Criteria:

  • There will be no exclusion criteria to maximize representation of the general population of Singaporean who are overweight and obese.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
600 participants (estimated)
Patient registry
No

Interventions

  • Otherno intervention

    National University Health System,

    Also known as: National University Health System,

06

What researchers measure

Primary outcomes

  1. Unified Theory of Acceptance and Use of Technology 2 (UTAUT2)

    Time frame: 2021-2023

Secondary outcomes

  1. Qualitative interviews

    Time frame: 2021-2023

07

Study locations

1 of 1 sites recruiting
  • National University of Singapore
    Singapore, 117597, Singapore
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 25, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05257239
Lead sponsor
National University Health System, Singapore
Responsible party
Jocelyn Chew (Research Fellow, National University Health System, Singapore) — Principal investigator
First posted
Feb 25, 2022
Start date
Feb 17, 2022
Primary completion
Feb 17, 2023 (estimated)
Completion
Jun 30, 2023 (estimated)
Last update
Feb 25, 2022

Study contacts

Jocelyn Chew
Contact
jocelyn.chew.hs@nus.edu.sg
+6565168687

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Body Weight→

Other studies from this sponsor

National University Health System, Singapore

Start the discussion